Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SoHi Partners is a venture builder and advisory firm founded in 2023 by a diverse team of experts in science, technology, medicine, business, and finance. The firm is headquartered in Bowral, Southern Highlands, New South Wales, Australia. Initially focused on global medical technology, SoHi Partners has expanded its investment strategy to include financial services and agriculture. The firm has a target fund size of $50 million, with initial commitments of $12 million secured within the first two months of its launch, primarily from surgeons and doctors.
SoHi Partners has a proven track record in technology investment management, boasting over 40 patents and multiple successful ventures among its founders. The firm emphasizes its commitment to addressing significant global challenges, such as population growth and the rise of non-communicable diseases, through innovative solutions in healthcare, agri-technology, and fintech. Notable milestones include the establishment of SoHi Labs, aimed at fostering medtech innovation.
SoHi Partners invests in innovative solutions across healthcare, agricultural, and financial sectors. The firm targets high-growth opportunities in agri-technology, fintech, and life sciences, aiming to address challenges posed by an increasing global population and rising non-communicable diseases. The investment strategy is centered around surgeon-led medtech investing, leveraging the clinical expertise of its founders to identify and commercialize medical research that traditional investment bankers often overlook.
Check sizes typically align with the firm's target fund size of $50 million, focusing on startups with a global market potential exceeding $1.5 billion and the capability for 20x returns. SoHi Partners seeks to partner with founders who demonstrate a strong vision and commitment to transforming their respective industries. The firm is open to co-investment opportunities, particularly in sectors where it can add significant value through its extensive network and clinical insights.
SoHi Partners has a diverse portfolio that includes notable companies in the healthcare and biotech sectors. Key portfolio companies include:
These companies exemplify SoHi Partners' commitment to investing in high-potential ventures that leverage cutting-edge technology to improve patient outcomes and address pressing healthcare challenges.
Dr. Nick Hartnell - Co-founder and orthopaedic surgeon, Dr. Hartnell co-founded Ginan Biomedics and brings extensive clinical expertise to the firm.
Dr. Ashish Diwan - Co-founder and orthopaedic surgeon, Dr. Diwan is also a co-founder of Cartago Biotech, focusing on innovative solutions for chronic pain.
Andrew Speers - Co-founder with a background in banking, Andrew previously held a position at Westfield, contributing business acumen to the firm.
John Bullwinkel - Co-founder with a banking background, John has experience from Lendlease, enhancing the firm's financial strategy.
To pitch to SoHi Partners, founders should use the contact information provided on their website. A well-structured pitch deck should include an overview of the business model, market analysis, competitive landscape, and details about the founding team. The firm prefers to receive pitches via email at info@sohipartners.com.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
In April 2023, SoHi Partners announced its initial commitments of $12 million within the first two months of its launch, primarily from surgeons and doctors. The firm is actively pursuing opportunities in healthcare, agtech, and fintech, with a focus on innovative solutions that address global challenges.
Additionally, SoHi Partners is seeking $5 million in funding for SoHi Labs, a medtech innovation lab aimed at fostering advancements in medical technology.
What are SoHi Partners' investment criteria?
SoHi Partners focuses on innovative solutions in healthcare, agtech, and fintech. The firm seeks startups with a global market potential exceeding $1.5 billion and the capability for 20x returns. They prioritize companies that address significant global challenges, such as population growth and non-communicable diseases.
How can I apply or pitch to SoHi Partners?
Founders can pitch their ideas through the firm's website at sohipartners.com. It is advisable to include a detailed business plan, market analysis, and information about the founding team in the pitch deck.
What makes SoHi Partners different from other venture capital firms?
SoHi Partners distinguishes itself through its surgeon-led investment approach, leveraging clinical expertise to identify and commercialize medical research that traditional investors may overlook. The firm also has a strong patent portfolio, which enhances its competitive edge in the medtech space.
What is the geographic scope of SoHi Partners' investments?
SoHi Partners invests globally, focusing on high-growth sectors in healthcare, agtech, and fintech. The firm aims to capitalize on opportunities that address global challenges, regardless of geographic location.
What type of post-investment involvement does SoHi Partners have?
SoHi Partners provides operational support and strategic guidance to its portfolio companies, leveraging its extensive network in the medical field to help navigate market complexities. The firm is actively involved in the development of its portfolio companies, particularly in the healthcare sector.
What is the typical check size for investments?
While specific check sizes are not disclosed, SoHi Partners operates within the framework of its $50 million fund, targeting investments that align with its strategic focus on high-growth opportunities in healthcare and technology.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.